FT vs PMTS

FT exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a very conservative balance sheet (Debt/Equity 0.29). The stock is significantly undervalued, trading at $8.14, which is well below both its Graham Number ($12.11) and estimated Intrinsic Value ($22.71). While the technical trend is bearish and revenue has contracted by 27.1%, the combination of a low P/E (10.57), a P/B under 1.0, and a sustainable 6.27% dividend yield makes it a compelling value play.

PMTS presents a classic deep-value opportunity, characterized by a stable Piotroski F-Score of 4/9 and a significant valuation gap between its current price ($17.89) and its intrinsic value ($26.94). While the negative Price/Book ratio indicates a precarious balance sheet with negative equity, the company's strong revenue growth (22.3%) and an exceptionally low Forward P/E of 5.17 suggest a recovery play. Recent short-term price momentum is positive, and analyst targets ($28.25) align with the growth-based intrinsic value. However, the lack of an Altman Z-Score and inconsistent earnings surprises necessitate a cautious approach to financial health.